Drug Profile
Research programme: neurological disorders therapeutics - Pfizer/UCI
Alternative Names: G protein-coupled receptor modulators - Pfizer; GPCR modulators - PfizerLatest Information Update: 13 Aug 2009
Price :
$50
*
At a glance
- Originator Pfizer; University of California at Irvine
- Class
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Neurological disorders
Most Recent Events
- 11 Dec 2002 NeoTherapeutics is now called Spectrum Pharmaceuticals
- 18 Apr 2001 Preclinical development for Neurological disorders in USA (Unknown route)